KNC Laboratories Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
927.00
2,093.00
2,172.00
916.00
585.00
704.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
789.00
1,057.00
-665.00
-1,110.00
-57.00
-1,005.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,487.00
3,204.00
1,993.00
585.00
1,326.00
42.00
Cash Flow from Investing Activities
-3,322.00
-2,369.00
-1,146.00
-613.00
-660.00
-1,863.00
Cash Flow from Financing Activities
909.00
178.00
-523.00
39.00
-180.00
254.00
Net Cash Inflow / Outflow
-925.00
1,014.00
323.00
10.00
486.00
-1,565.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of KNC Laboratories Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
927.993
1181.853
-254.00
-21.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
789.957
-37.122
826.00
2228.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1487.123
663.808
824.00
124.03%
Cash Flow from Investing Activities
-3322.708
-4092.267
770.00
18.81%
Cash Flow from Financing Activities
909.599
-150.111
1,059.00
705.95%
Net Cash Inflow / Outflow
-925.986
-3558.738
2,633.00
73.98%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
19.832
-19.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -53.59% vs 60.71% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
1,487.12
3,204.54
-53.59%






